stockrow
Friday 6 November 2026
Export ZOMDF’s income statement to Excel — free account
Zomedica Corp.
ZOMDF Healthcare Medical Devices
Zomedica Corp.’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 17.4% from fiscal 2024.
- Revenue
- +22.3%
- EPS
- +48.4%
- Free cash flow
- +32.5%
Quarter to September 2026, against a year earlier
0.09
0.00
0.00%
Follow ZOMDF
Alert me
| Sep '26 From the 10-Q filed 4 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 5 | 4 |
+8 more TTM periods Free account |
| (14.28%) | (16.29%) | (18.56%) | (52.63%) | ||
| (13.01%) | (14.88%) | (17.07%) | (48.96%) | ||
ROIC |
(17.12%) | (20.54%) | (24.34%) | (84.84%) | |
Return on Tangible Assets |
(24.27%) | (27.49%) | (31.40%) | (108.41%) | |
Average Days of Receivables |
67.72 | 59.63 | 51.05 | 39.37 | |
Free Cash Flow per Share |
(0.01) | (0.02) | (0.02) | (0.02) | |
Free Cash Flow |
(13.46) | (15.03) | (17.32) | (18.59) | |
Capital Expenditures |
(1.99) | (1.66) | (1.06) | (0.95) | |
| Other line items | |||||
Cash ROIC |
(9.32%) | (9.92%) | (10.93%) | (11.03%) | |
Accounts Receivable Turnover |
7.16 | 8.25 | 9.91 | 9.82 | |
Accounts Payable Turnover |
7.45 | 7.00 | 5.15 | 5.68 | |
Inventory Turnover |
2.47 | 2.17 | 2.06 | 1.95 | |
Average Days of Payables |
54.93 | 44.96 | 69.39 | 60.58 | |
Days of Inventory on Hand |
151.14 | 173.25 | 185.29 | 195.53 | |
Tax Rate |
(0.01) | (0.01) | (0.01) | 0.00 | |
Research and Development Expense of Revenue |
13.11% | 15.32% | 18.84% | 22.37% | |
Selling, General and Administrative Expense of Revenue |
96.27% | 106.39% | 119.42% | 134.35% | |
Share Based Compensation of Revenue |
3.62% | 6.25% | 7.27% | 7.72% | |
Operating CF/Net income |
0.72 | 0.71 | 0.72 | 0.22 | |
Depreciation/Fixed assets |
0.00 | 0.36 | 0.35 | 0.35 | |
Capex/Depreciation |
0.00 | (0.23) | (0.15) | (0.13) | |
Revenue per Share |
0.04 | 0.04 | 0.04 | 0.03 | |
Operating CF per Share |
(0.01) | (0.01) | (0.02) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.05 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 4 Nov 2026